Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis

References

• Masutani C, Kusumoto R, Yamada A, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature. 1999;399:700–704. doi:10.1038/21447. PMID:10385124
   PubMed Web of Science ®Google Scholar
• Rogozin IB, Goncearenco A, Lada AG, et al. DNA polymerase eta mutational signatures are found in a variety of different types of cancer. Cell Cycle. 2018;17(3):348–355. doi:10.1080/15384101.2017.1404208.
   PubMed Web of Science ®Google Scholar
• Gao Y, Mutter-Rottmayer E, Greenwalt AM, et al. A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. Nat Commun. 2016;7:12105. doi:10.1038/ncomms12105. PMID:27377895
   PubMed Web of Science ®Google Scholar
• Gao Y, Tateishi S, Vaziri C. Pathological trans-lesion synthesis in cancer. Cell Cycle. 2016;15(22):3005–3006. doi:10.1080/15384101.2016.1214045.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao Y, Mutter-Rottmayer L, et al. DNA repair factor RAD18 and DNA polymerase Polkappa confer tolerance of oncogenic DNA replication stress. J Cell Biol. 2017;216(10):3097. doi:10.1083/jcb.201702006.
   PubMed Web of Science ®Google Scholar
• Albertella MR, Green CM, Lehmann AR, et al. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res. 2005;65:9799–9806. doi:10.1158/0008-5472.CAN-05-1095. PMID:16267001
   PubMed Web of Science ®Google Scholar
• Zhao Y, Biertumpfel C, Gregory MT, et al. Structural basis of human DNA polymerase eta-mediated chemoresistance to cisplatin. Proc Natl Acad Sci USA. 2012;109:7269–7274. doi:10.1073/pnas.1202681109. PMID:22529383
   PubMed Web of Science ®Google Scholar
• Masutani C, Araki M, Yamada A, et al. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. Embo J. 1999;18:3491–3501. doi:10.1093/emboj/18.12.3491. PMID:10369688
   PubMed Web of Science ®Google Scholar
• Ziv O, Geacintov N, Nakajima S, et al. DNA polymerase zeta cooperates with polymerases kappa and iota in translesion DNA synthesis across pyrimidine photodimers in cells from XPV patients. Proc Natl Acad Sci USA. 2009;106:11552–11557. doi:10.1073/pnas.0812548106. PMID:19564618
   PubMed Web of Science ®Google Scholar
• Shachar S, Ziv O, Avkin S, et al. Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals. EMBO J. 2009;28:383–393. doi:10.1038/emboj.2008.281. PMID:19153606
   PubMed Web of Science ®Google Scholar
• Ohmori H, Ohashi E, Ogi T. Mammalian Pol kappa: regulation of its expression and lesion substrates. Adv Protein Chem. 2004;69:265–278. doi:10.1016/S0065-3233(04)69009-7. PMID:15588846
   PubMedGoogle Scholar
• Ulrich HD, Jentsch S. Two RING finger proteins mediate cooperation between ubiquitin-conjugating enzymes in DNA repair. EMBO J. 2000;19:3388–3397. doi:10.1093/emboj/19.13.3388. PMID:10880451
   PubMed Web of Science ®Google Scholar
• Kannouche PL, Wing J, Lehmann AR. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol Cell. 2004;14:491–500. doi:10.1016/S1097-2765(04)00259-X. PMID:15149598
   PubMed Web of Science ®Google Scholar
• Davies AA, Huttner D, Daigaku Y, et al. Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein a. Mol Cell. 2008;29:625–636. doi:10.1016/j.molcel.2007.12.016. PMID:18342608
   PubMed Web of Science ®Google Scholar
• Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 2003;300:1542–1548. doi:10.1126/science.1083430. PMID:12791985
   PubMed Web of Science ®Google Scholar
• Yang Y, Durando M, Smith-Roe SL, et al. Cell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage. Nucleic Acids Res. 2013;41(4):2296–2312. doi:10.1093/nar/gks1325.
   PubMed Web of Science ®Google Scholar
• Zlatanou A, Despras E, Braz-Petta T, et al. The hMsh2-hMsh6 complex acts in concert with monoubiquitinated PCNA and Pol eta in response to oxidative DNA damage in human cells. Mol Cell. 2011;43:649–662. doi:10.1016/j.molcel.2011.06.023. PMID:21855803
   PubMed Web of Science ®Google Scholar
• Ogi T, Limsirichaikul S, Overmeer RM, et al. Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells. Mol Cell. 2010;37:714–727. doi:10.1016/j.molcel.2010.02.009. PMID:20227374
   PubMed Web of Science ®Google Scholar
• Bienko M, Green CM, Crosetto N, et al. Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science. 2005;310:1821–1824. doi:10.1126/science.1120615. PMID:16357261
   PubMed Web of Science ®Google Scholar
• Watanabe K, Tateishi S, Kawasuji M, et al. Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. Embo J. 2004;23:3886–3896. doi:10.1038/sj.emboj.7600383. PMID:15359278
   PubMed Web of Science ®Google Scholar
• Durando M, Tateishi S, Vaziri C. A non-catalytic role of DNA polymerase eta in recruiting Rad18 and promoting PCNA monoubiquitination at stalled replication forks. Nucleic Acids Res. 2013;41(5):3079–3093. doi:10.1093/nar/gkt016.
   PubMed Web of Science ®Google Scholar
• Rogozin IB, Pavlov YI, Goncearenco A, et al. Mutational signatures and mutable motifs in cancer genomes. Brief Bioinform. 2017;1–17. doi:10.1093/bib/bbx049. PMID:28498882
   PubMedGoogle Scholar
• Alexandrov LB, Stratton MR. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Gene Dev. 2014;24:52–60. doi:10.1016/j.gde.2013.11.014.
   PubMed Web of Science ®Google Scholar
• Temiz NA, Donohue DE, Bacolla A, et al. The somatic autosomal mutation matrix in cancer genomes. Hum Genet. 2015;134:851–864. doi:10.1007/s00439-015-1566-1. PMID:26001532
   PubMed Web of Science ®Google Scholar
• Goncearenco A, Rager SL, Li M, et al. Exploring background mutational processes to decipher cancer genetic heterogeneity. Nucleic Acids Res. 2017;45(W1):W514–W522. doi:10.1093/nar/gkx367. PMID:28472504
   PubMed Web of Science ®Google Scholar
• Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415–21. doi:10.1038/nature12477. PMID:23945592
   PubMed Web of Science ®Google Scholar
• Roberts SA, Sterling J, Thompson C, et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol Cell. 2012;46:424–435. doi:10.1016/j.molcel.2012.03.030. PMID:22607975
   PubMed Web of Science ®Google Scholar
• Chan K, Gordenin DA. Clusters of multiple mutations: incidence and molecular mechanisms. Annu Rev Genet. 2015;49:243–67. doi:10.1146/annurev-genet-112414-054714. PMID:26631512
   PubMed Web of Science ®Google Scholar
• Tsuji Y, Watanabe K, Araki K, et al. Recognition of forked and single-stranded DNA structures by human RAD18 complexed with RAD6B protein triggers its recruitment to stalled replication forks. Genes Cells. 2008;13:343–354. doi:10.1111/j.1365-2443.2008.01176.x. PMID:18363965
   PubMed Web of Science ®Google Scholar
• Buisson R, Lawrence MS, Benes CH, et al. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition. Cancer Res. 2017;77:4567–4578. doi:10.1158/0008-5472.CAN-16-3389. PMID:28698210
   PubMed Web of Science ®Google Scholar
• Mayorov VI, Rogozin IB, Adkison LR, et al. DNA polymerase eta contributes to strand bias of mutations of A versus T in immunoglobulin genes. J Immunol. 2005;174:7781–7786. doi:10.4049/jimmunol.174.12.7781. PMID:15944281
   PubMed Web of Science ®Google Scholar
• Rogozin IB, Lada AG, Goncearenco A, et al. Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers. Sci Rep. 2016;6:38133. doi:10.1038/srep38133. PMID:27924834
   PubMed Web of Science ®Google Scholar
• Supek F, Lehner B. Clustered mutation signatures reveal that error-prone DNA repair targets mutations to active genes. Cell. 2017;170:534–547, e23. doi:10.1016/j.cell.2017.07.003. PMID:28753428
   PubMed Web of Science ®Google Scholar
• Li F, Mao G, Tong D, et al. The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSalpha. Cell. 2013;153:590–600. doi:10.1016/j.cell.2013.03.025. PMID:23622243
   PubMed Web of Science ®Google Scholar
• Frigola J, Sabarinathan R, Mularoni L, et al. Reduced mutation rate in exons due to differential mismatch repair. Nat Genet. 2017;49:1684–1692. doi:10.1038/ng.3991. PMID:29106418
   PubMed Web of Science ®Google Scholar
• Rogozin IB, Pavlov YI, Bebenek K, et al. Somatic mutation hotspots correlate with DNA polymerase eta error spectrum. Nat Immunol. 2001;2:530–536. doi:10.1038/88732. PMID:11376340
   PubMed Web of Science ®Google Scholar
• Yeom M, Kim IH, Kim JK, et al. Effects of twelve germline missense variations on DNA lesion and G-Quadruplex bypass activities of human DNA polymerase REV1. Chem Res Toxicol. 2016;29:367–379. doi:10.1021/acs.chemrestox.5b00513. PMID:26914252
   PubMed Web of Science ®Google Scholar
• Sakiyama T, Kohno T, Mimaki S, et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer. 2005;114:730–737. doi:10.1002/ijc.20790. PMID:15609317
   PubMed Web of Science ®Google Scholar
• Xu HL, Gao XR, Zhang W, et al. Effects of polymorphisms in translesion DNA synthesis genes on lung cancer risk and prognosis in Chinese men. Cancer Epidemiol. 2013;37:917–922. doi:10.1016/j.canep.2013.08.003. PMID:24012694
   PubMed Web of Science ®Google Scholar
• Dai ZJ, Liu XH, Ma YF, et al. Association between single nucleotide polymorphisms in DNA polymerase kappa gene and breast cancer risk in Chinese han population: a STROBE-compliant observational study. Medicine. 2016;95:e2466. doi:10.1097/MD.0000000000002466. PMID:26765445
   PubMed Web of Science ®Google Scholar
• Yang J, Chen Z, Liu Y, et al. Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res. 2004;64:5597–5607. doi:10.1158/0008-5472.CAN-04-0603. PMID:15313897
   PubMed Web of Science ®Google Scholar
• Sasatani M, Xi Y, Kajimura J, et al. Overexpression of Rev1 promotes the development of carcinogen-induced intestinal adenomas via accumulation of point mutation and suppression of apoptosis proportionally to the Rev1 expression level. Carcinogenesis. 2017;38:570–578. doi:10.1093/carcin/bgw208. PMID:28498946
   PubMed Web of Science ®Google Scholar
• Albertella MR, Lau A, O'Connor MJ. The overexpression of specialized DNA polymerases in cancer. DNA Repair (Amst). 2005;4:583–593. doi:10.1016/j.dnarep.2005.01.005. PMID:15811630
   PubMed Web of Science ®Google Scholar
• Bavoux C, Leopoldino AM, Bergoglio V, et al. Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis. Cancer Res. 2005;65:325–330. PMID:15665310
   PubMed Web of Science ®Google Scholar
• Yuan F, Xu Z, Yang M, et al. Overexpressed DNA polymerase iota regulated by JNK/c-Jun contributes to hypermutagenesis in bladder cancer. PloS One. 2013;8:e69317. doi:10.1371/journal.pone.0069317. PMID:23922701
   PubMed Web of Science ®Google Scholar
• Wang H, Wu W, Wang HW, et al. Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance. Neuro Oncol. 2010;12:679–686. doi:10.1093/neuonc/nop074. PMID:20164241
   PubMed Web of Science ®Google Scholar
• Ziv O, Zeisel A, Mirlas-Neisberg N, et al. Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin. Nat Commun. 2014;5:5437. doi:10.1038/ncomms6437. PMID:25421715
   PubMed Web of Science ®Google Scholar
• Despras E, Sittewelle M, Pouvelle C, et al. Rad18-dependent SUMOylation of human specialized DNA polymerase eta is required to prevent under-replicated DNA. Nat Commun. 2016;7:13326. doi:10.1038/ncomms13326. PMID:27811911
   PubMed Web of Science ®Google Scholar
• Garcia-Exposito L, Bournique E, Bergoglio V, et al. Proteomic profiling reveals a specific role for translesion DNA polymerase eta in the alternative lengthening of telomeres. Cell Rep. 2016;17:1858–1871. doi:10.1016/j.celrep.2016.10.048. PMID:27829156
   PubMed Web of Science ®Google Scholar
• Rey L, Sidorova JM, Puget N, et al. Human DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication. Mol Cell Biol. 2009;29:3344–3354. doi:10.1128/MCB.00115-09. PMID:19380493
   PubMed Web of Science ®Google Scholar
• Bergoglio V, Boyer AS, Walsh E, et al. DNA synthesis by Pol eta promotes fragile site stability by preventing under-replicated DNA in mitosis. J Cell Biol. 2013;201:395–408. doi:10.1083/jcb.201207066. PMID:23609533
   PubMed Web of Science ®Google Scholar
• Bartkova J, Rezaei N, Liontos M, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 2006;444:633–637. doi:10.1038/nature05268. PMID:17136093
   PubMed Web of Science ®Google Scholar
• Di Micco R, Fumagalli M, Cicalese A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444:638–642. doi:10.1038/nature05327. PMID:17136094
   PubMed Web of Science ®Google Scholar
• Bartek J, Bartkova J, Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene. 2007;26:7773–7779. doi:10.1038/sj.onc.1210881. PMID:18066090
   PubMed Web of Science ®Google Scholar
• Bartek J, Lukas J, Bartkova J. DNA damage response as an anti-cancer barrier: damage threshold and the concept of ‘conditional haploinsufficiency’. Cell Cycle. 2007;6:2344–2347. doi:10.4161/cc.6.19.4754. PMID:17700066
   PubMed Web of Science ®Google Scholar
• Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864–870. doi:10.1038/nature03482. PMID:15829956
   PubMed Web of Science ®Google Scholar
• Neelsen KJ, Zanini IM, Mijic S, et al. Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template. Genes Dev. 2013;27:2537–2542. doi:10.1101/gad.226373.113. PMID:24298053
   PubMed Web of Science ®Google Scholar
• Vaziri C, Saxena S, Jeon Y, et al. A p53-dependent checkpoint pathway prevents rereplication. Mol Cell. 2003;11:997–1008. doi:10.1016/S1097-2765(03)00099-6. PMID:12718885
   PubMed Web of Science ®Google Scholar
• Jones RM, Mortusewicz O, Afzal I, et al. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress. Oncogene. 2013;32:3744–3753. doi:10.1038/onc.2012.387. PMID:22945645
   PubMed Web of Science ®Google Scholar
• Kotsantis P, Silva LM, Irmscher S, et al. Increased global transcription activity as a mechanism of replication stress in cancer. Nat Commun. 2016;7:13087. doi:10.1038/ncomms13087. PMID:27725641
   PubMed Web of Science ®Google Scholar
• Hamperl S, Bocek MJ, Saldivar JC, et al. Transcription-replication conflict orientation modulates R-loop levels and activates distinct DNA damage responses. Cell. 2017;170:774–786, e19.
   PubMed Web of Science ®Google Scholar
• Macheret M, Halazonetis TD. Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress. Nature. 2018;555:112–116. doi:10.1038/nature25507. PMID:29466339
   PubMed Web of Science ®Google Scholar
• Irani K, Xia Y, Zweier JL, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 1997;275:1649–1652. doi:10.1126/science.275.5306.1649. PMID:9054359
   PubMed Web of Science ®Google Scholar
• Lee AC, Fenster BE, Ito H, et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem. 1999;274:7936–7940. doi:10.1074/jbc.274.12.7936. PMID:10075689
   PubMed Web of Science ®Google Scholar
• Ogrunc M, Di Micco R, Liontos M, et al. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ. 2014;21:998–1012. doi:10.1038/cdd.2014.16. PMID:24583638
   PubMed Web of Science ®Google Scholar
• Vafa O, Wade M, Kern S, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002;9:1031–1044. doi:10.1016/S1097-2765(02)00520-8. PMID:12049739
   PubMed Web of Science ®Google Scholar
• Moiseeva O, Bourdeau V, Roux A, et al. Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol. 2009;29:4495–507. doi:10.1128/MCB.01868-08. PMID:19528227
   PubMed Web of Science ®Google Scholar
• Maya-Mendoza A, Ostrakova J, Kosar M, et al. Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress. Molecular oncology. 2015;9:601–616. doi:10.1016/j.molonc.2014.11.001. PMID:25435281
   PubMed Web of Science ®Google Scholar
• Bester AC, Roniger M, Oren YS, et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell. 2011;145:435–446. doi:10.1016/j.cell.2011.03.044. PMID:21529715
   PubMed Web of Science ®Google Scholar
• Srinivasan SV, Dominguez-Sola D, Wang LC, et al. Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell Rep. 2013;3:1629–1639. doi:10.1016/j.celrep.2013.04.002. PMID:23643534
   PubMed Web of Science ®Google Scholar
• Costantino L, Sotiriou SK, Rantala JK, et al. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science. 2014;343:88–91. doi:10.1126/science.1243211. PMID:24310611
   PubMed Web of Science ®Google Scholar
• Gilad O, Nabet BY, Ragland RL, et al. Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner. Cancer Res. 2010;70:9693–9702. doi:10.1158/0008-5472.CAN-10-2286. PMID:21098704
   PubMed Web of Science ®Google Scholar
• Petta TB, Nakajima S, Zlatanou A, et al. Human DNA polymerase iota protects cells against oxidative stress. Embo J. 2008;27:2883–2895. doi:10.1038/emboj.2008.210. PMID:18923427
   PubMed Web of Science ®Google Scholar
• Watanabe T, Marotta M, Suzuki R, et al. Impediment of replication forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone Restart. Cell Rep. 2017;21:2223–2235. doi:10.1016/j.celrep.2017.10.103. PMID:29166612
   PubMed Web of Science ®Google Scholar
• Neelsen KJ, Zanini IM, Herrador R, et al. Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates. J Cell Biol. 2013;200:699–708. doi:10.1083/jcb.201212058. PMID:23479741
   PubMed Web of Science ®Google Scholar
• Fikaris AJ, Lewis AE, Abulaiti A, et al. Ras triggers ataxia-telangiectasia-mutated and Rad-3-related activation and apoptosis through sustained mitogenic signaling. J Biol Chem. 2006;281:34759–34767. doi:10.1074/jbc.M606737200. PMID:16968694
   PubMed Web of Science ®Google Scholar
• Daigaku Y, Davies AA, Ulrich HD. Ubiquitin-dependent DNA damage bypass is separable from genome replication. Nature. 2010;465:951–955. doi:10.1038/nature09097. PMID:20453836
   PubMed Web of Science ®Google Scholar
• Betous R, Rey L, Wang G, et al. Role of TLS DNA polymerases eta and kappa in processing naturally occurring structured DNA in human cells. Mol Carcinog. 2009;48:369–378. doi:10.1002/mc.20509. PMID:19117014
   PubMed Web of Science ®Google Scholar
• Cea V, Cipolla L, Sabbioneda S. Replication of structured DNA and its implication in epigenetic stability. Front Genet. 2015;6:209. doi:10.3389/fgene.2015.00209. PMID:26136769
   PubMed Web of Science ®Google Scholar
• Eddy S, Tillman M, Maddukuri L, et al. Human translesion polymerase kappa exhibits enhanced activity and reduced fidelity two nucleotides from G-quadruplex DNA. Biochemistry. 2016;55(37):5218–5229. doi:10.1021/acs.biochem.6b00374. PMID:27525498
   PubMed Web of Science ®Google Scholar
• Hile SE, Wang X, Lee MY, et al. Beyond translesion synthesis: polymerase kappa fidelity as a potential determinant of microsatellite stability. Nucleic Acids Res. 2012;40:1636–1647. doi:10.1093/nar/gkr889. PMID:22021378
   PubMed Web of Science ®Google Scholar
• Bartek J, Mistrik M, Bartkova J. Thresholds of replication stress signaling in cancer development and treatment. Nat Struct Mol Biol. 2012;19:5–7. doi:10.1038/nsmb.2220. PMID:22218289
   PubMed Web of Science ®Google Scholar
• Bi X, Barkley LR, Slater DM, et al. Rad18 regulates DNA polymerase kappa and is required for recovery from S-phase checkpoint-mediated arrest. Mol Cell Biol. 2006;26:3527–3540. doi:10.1128/MCB.26.9.3527-3540.2006. PMID:16611994
   PubMed Web of Science ®Google Scholar
• Bi X, Slater DM, Ohmori H, et al. DNA polymerase kappa is specifically required for recovery from the benzo[a]pyrene-dihydrodiol epoxide (BPDE)-induced S-phase checkpoint. J Biol Chem. 2005;280:22343–22355. doi:10.1074/jbc.M501562200. PMID:15817457
   PubMed Web of Science ®Google Scholar
• Murga M, Campaner S, Lopez-Contreras AJ, et al. Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat Struct Mol Biol. 2011;18:1331–1335. doi:10.1038/nsmb.2189. PMID:22120667
   PubMed Web of Science ®Google Scholar
• Ceccaldi R, Liu JC, Amunugama R, et al. Homologous-recombination-deficient tumours are dependent on Poltheta-mediated repair. Nature. 2015;518:258–262. doi:10.1038/nature14184. PMID:25642963
   PubMed Web of Science ®Google Scholar
• Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573–584. doi:10.1038/nrc2167. PMID:17625587
   PubMed Web of Science ®Google Scholar
• Mamenta EL, Poma EE, Kaufmann WK, et al. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res. 1994;54:3500–3505. PMID:8012973
   PubMed Web of Science ®Google Scholar
• Kunz BA, Straffon AF, Vonarx EJ. DNA damage-induced mutation: tolerance via translesion synthesis. Mutat Res. 2000;451:169–185. doi:10.1016/S0027-5107(00)00048-8. PMID:10915871
   PubMed Web of Science ®Google Scholar
• Lehmann AR. Replication of damaged DNA by translesion synthesis in human cells. FEBS Lett. 2005;579:873–876. doi:10.1016/j.febslet.2004.11.029. PMID:15680966
   PubMed Web of Science ®Google Scholar
• Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481(7381):287–294. doi:10.1038/nature10760. PMID:22258607
   PubMed Web of Science ®Google Scholar
• Ummat A, Rechkoblit O, Jain R, et al. Structural basis for cisplatin DNA damage tolerance by human polymerase eta during cancer chemotherapy. Nat Struct Mol Biol. 2012;19:628–632. doi:10.1038/nsmb.2295. PMID:22562137
   PubMed Web of Science ®Google Scholar
• Alt A, Lammens K, Chiocchini C, et al. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta. Science. 2007;318:967–970. doi:10.1126/science.1148242. PMID:17991862
   PubMed Web of Science ®Google Scholar
• Chen YW, Cleaver JE, Hanaoka F, et al. A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents. Mol Cancer Res. 2006;4:257–265. doi:10.1158/1541-7786.MCR-05-0118. PMID:16603639
   PubMed Web of Science ®Google Scholar
• Wagner JM, Karnitz LM. Cisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survival. Mol Pharmacol. 2009;76:208–214. doi:10.1124/mol.109.055178. PMID:19403702
   PubMed Web of Science ®Google Scholar
• Yamashita YM, Okada T, Matsusaka T, et al. RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells. Embo J. 2002;21:5558–5566. doi:10.1093/emboj/cdf534. PMID:12374756
   PubMed Web of Science ®Google Scholar
• Ceppi P, Novello S, Cambieri A, et al. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res. 2009;15:1039–1045. doi:10.1158/1078-0432.CCR-08-1227. PMID:19188177
   PubMed Web of Science ®Google Scholar
• Teng KY, Qiu MZ, Li ZH, et al. DNA polymerase eta protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy. J Transl Med. 2010;8:126. doi:10.1186/1479-5876-8-126. PMID:21110884
   PubMed Web of Science ®Google Scholar
• Ma CX, Janetka JW, Piwnica-Worms H. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol Med. 2011;17:88–96. doi:10.1016/j.molmed.2010.10.009. PMID:21087899
   PubMed Web of Science ®Google Scholar
• Karnitz LM, Zou L. Molecular pathways: targeting ATR in cancer therapy. Clin Cancer Res. 2015;21:4780–4785. doi:10.1158/1078-0432.CCR-15-0479. PMID:26362996
   PubMed Web of Science ®Google Scholar
• Brandsma I, Fleuren EDG, Williamson CT, et al. Directing the use of DDR kinase inhibitors in cancer treatment. Expert Opin Investig Drugs. 2017;26:1341–1355. doi:10.1080/13543784.2017.1389895. PMID:28984489
   PubMed Web of Science ®Google Scholar
• Toledo LI, Murga M, Zur R, et al. A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nat Struct Mol Biol. 2011;18:721–727. doi:10.1038/nsmb.2076. PMID:21552262
   PubMed Web of Science ®Google Scholar
• Reaper PM, Griffiths MR, Long JM, et al. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR. Nat Chem Biol. 2011;7:428–430. doi:10.1038/nchembio.573. PMID:21490603
   PubMed Web of Science ®Google Scholar
• Huntoon CJ, Flatten KS, Wahner Hendrickson AE, et al. ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. Cancer Res. 2013;73:3683–3691. doi:10.1158/0008-5472.CAN-13-0110. PMID:23548269
   PubMed Web of Science ®Google Scholar
• Maher VM, Ouellette LM, Curren RD, et al. Caffeine enhancement of the cytotoxic and mutagenic effect of ultraviolet irradiation in a xeroderma pigmentosum variant strain of human cells. Biochem Biophys Res Commun. 1976;71:228–234. doi:10.1016/0006-291X(76)90272-2. PMID:962915
   PubMed Web of Science ®Google Scholar
• Despras E, Daboussi F, Hyrien O, et al. ATR/Chk1 pathway is essential for resumption of DNA synthesis and cell survival in UV-irradiated XP variant cells. Hum Mol Genet. 2010;19:1690–1701. doi:10.1093/hmg/ddq046. PMID:20123862
   PubMed Web of Science ®Google Scholar
• Mohni KN, Thompson PS, Luzwick JW, et al. A synthetic lethal screen identifies DNA repair pathways that sensitize cancer cells to combined ATR inhibition and cisplatin treatments. PloS One. 2015;10:e0125482. doi:10.1371/journal.pone.0125482. PMID:25965342
   PubMed Web of Science ®Google Scholar
• Sakurikar N, Thompson R, Montano R, et al. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase. Oncotarget. 2016;7:1380–1394. doi:10.18632/oncotarget.6364. PMID:26595527
   PubMed Web of Science ®Google Scholar